Robin Vacha Azenta, Inc. (AZTA) insider trading activity

Robin Vacha is SVP, GM Life Science Products of Azenta, Inc.. Currently has a direct ownership of 31,287 shares of AZTA, which is worth approximately $1.61 Million. The most recent transaction as insider was on Feb 01, 2024, when has been sold 324 shares (Common) at a price of $39.41 per share, resulting in proceeds of $12,768. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.3K

0% 3M change

21.32% 12M change

Total Value Held $1.61 Million

Robin Vacha Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2024	BUY Grant, award, or other acquisition	$12,768 $39.41 p/Share	324 Added 1.02%	31,287 Common
Jan 31 2024	BUY Grant, award, or other acquisition	$8,004 $53.01 p/Share	151 Added 0.48%	31,438 Common
Dec 05 2023	SELL Sale (or disposition) back to the issuer	$292,905 $56.6 p/Share	5,175 Reduced 16.71%	25,788 Common
Nov 16 2023	SELL Sale (or disposition) back to the issuer	$158,524 $53.81 p/Share	2,946 Reduced 10.05%	26,381 Common Stock
Nov 16 2023	BUY Grant, award, or other acquisition	$250,039 $54.57 p/Share	4,582 Added 12.89%	30,963 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	$222,311 $54.13 p/Share	4,107 Added 12.28%	29,327 Common Stock
Aug 10 2023	SELL Grant, award, or other acquisition	$407,000 $55.0 p/Share	7,400 Reduced 22.69%	25,220 Common Stock
Jul 31 2023	BUY Grant, award, or other acquisition	$4,837 $39.98 p/Share	121 Added 0.37%	32,620 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	$12,433 $46.92 p/Share	265 Added 0.81%	32,499 Common Stock
Nov 17 2022	BUY Grant, award, or other acquisition	-	3,778 Added 10.49%	32,234 Common Stock
Nov 15 2022	SELL Payment of exercise price or tax liability	-	5,838 Reduced 17.02%	28,456 Common Stock
Nov 15 2022	BUY Grant, award, or other acquisition	-	11,077 Added 24.41%	34,294 Common Stock
Jan 31 2022	BUY Grant, award, or other acquisition	$19,748 $69.29 p/Share	285 Added 1.21%	23,217 Common Stock
Nov 18 2021	SELL Open market or private sale	$772,505 $119.03 p/Share	6,490 Reduced 22.06%	22,932 Common Stock
Nov 17 2021	SELL Open market or private sale	$1,058,879 $119.27 p/Share	8,878 Reduced 23.18%	29,422 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	19,102 Added 33.64%	37,677 Common Stock
Jul 31 2021	BUY Grant, award, or other acquisition	-	221 Added 0.57%	38,300 Common
Jan 31 2021	BUY Grant, award, or other acquisition	-	402 Added 1.04%	38,079 Common Stock
Nov 18 2020	SELL Open market or private sale	$451,834 $69.62 p/Share	6,490 Reduced 25.89%	18,575 Common Stock
Nov 13 2020	BUY Grant, award, or other acquisition	-	14,684 Added 36.94%	25,065 Common Stock

Robin Vacha

SVP, GM Life Science Products

Chelmsford, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AZTA shares.

Notify only if

Value

Insider Trading

Get notified when an Azenta, Inc. insider buys or sells AZTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Azenta, Inc.

Track Activities on AZTA

Account